These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 878010)

  • 1. Evidence for related antigens on sperm, tumor, and fetal cells in the mouse.
    Goldberg EH; Tokuda S
    Transplant Proc; 1977 Jun; 9(2):1363-5. PubMed ID: 878010
    [No Abstract]   [Full Text] [Related]  

  • 2. Fetal antigens associated with adenovirus 12 mouse tumors.
    Akagi T
    Acta Med Okayama; 1976 Dec; 30(6):385-95. PubMed ID: 138333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of tumor and histocompatibility antigens in sera of lymphoma-bearing mice.
    Fujimoto S; Chen CH; Sabbadini E; Sehon AH
    J Immunol; 1973 Oct; 111(4):1093-100. PubMed ID: 4728678
    [No Abstract]   [Full Text] [Related]  

  • 4. In vivo studies of the role of cytotoxic T cells in tumor allograft immunity.
    Freedman LR; Cerottini JC; Brunner KT
    J Immunol; 1972 Dec; 109(6):1371-8. PubMed ID: 4538966
    [No Abstract]   [Full Text] [Related]  

  • 5. Depression of alloantigens in malignancy. Evidence for tumour susceptibility alloantigens and for possible self-reactivity of lymphoid cells active in the microcytotoxicity assay.
    Martin WJ; Esber E; Cotton WG; Rice JM
    Br J Cancer Suppl; 1973 Aug; 1():48-61. PubMed ID: 4804290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fetal growth modified by natural and induced changes in maternal reactivity.
    Breyere EJ
    Cancer Res; 1976 Sep; 36(9 PT 2):3441-5. PubMed ID: 975102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytotoxicity of vivo sensitized lymphocytes on allogeneic third-party fibroblasts differing for various regions of the H-2 complex.
    Jorgensen PN; Florentz K; Güttler F
    Transplant Proc; 1974 Mar; 6(1):95-9. PubMed ID: 4817057
    [No Abstract]   [Full Text] [Related]  

  • 8. Transplantability and antigenicity of two sublines of the TA3 tumor.
    Sanford BH; Codington JF; Jeanloz RW; Palmer PD
    J Immunol; 1973 May; 110(5):1233-7. PubMed ID: 4572632
    [No Abstract]   [Full Text] [Related]  

  • 9. Analysis of a fetal calf serum-induced T cell line. I. H-2 restricted growth and expression of membrane-bound and released molecules bearing 5936-idiotypic determinants.
    Suzan M; Bourgois A; Boned A; De Preval C; Golstein P; Rubin B
    J Immunol; 1981 Sep; 127(3):992-9. PubMed ID: 6167637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specificity of immune paralysis at large tumor volumes.
    Pardridge DH; Wang BS; Mannick JA; Deckers PJ
    Surg Forum; 1975; 26():118-20. PubMed ID: 56046
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunogenicity and enhancement of normal and tumor tissue in the mouse.
    McKenzie IF; Snell GD
    Transplant Proc; 1973 Mar; 5(1):953-6. PubMed ID: 4572155
    [No Abstract]   [Full Text] [Related]  

  • 12. Subsets of oncofetal antigen-induced T-cells: ability to mediate antitumor immune response.
    Gautam S; Deodhar SD
    J Natl Cancer Inst; 1983 May; 70(5):923-30. PubMed ID: 6601736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of murine oncofetal antigens as tumor-associated transplantation antigens.
    Chism SE; Wallis S; Burton RC; Warner NL
    J Immunol; 1976 Nov; 117(5 Pt.2):1870-7. PubMed ID: 993583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ovarian tumor antigens: a new potential for therapy.
    Order SE; Thurnston J; Knapp R
    Natl Cancer Inst Monogr; 1975 Oct; 42():33-43. PubMed ID: 1234634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sensitization of T lymphocytes in vitro by syngeneic macrophages fed with tumor antigens.
    Treves AJ; Schechter B; Cohen IR; Feldman M
    J Immunol; 1976 Apr; 116(4):1059-64. PubMed ID: 1082902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Syngeneic and allogeneic mouse lymphoma antisera: specificity, reaction with fetal antigen and protective capacity.
    Prager MD; Granatek CH; Ludden CM
    Isr J Med Sci; 1976; 12(4-5):325-33. PubMed ID: 939692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro sensitization and induction of syngeneic tumor--specific cell--mediated cytotoxicity.
    Ferguson RM; Moe M; Simmons RL
    Surg Forum; 1976; 27(62):117-9. PubMed ID: 1032910
    [No Abstract]   [Full Text] [Related]  

  • 18. The biologic effects of allogeneic factor on T lymphocytes. II. The specificity of AEF-induced cytotoxic T lymphocytes.
    Altman A; Cardenas JM; Bechtold TE; Katz DH
    J Immunol; 1980 Jan; 124(1):114-20. PubMed ID: 6153087
    [No Abstract]   [Full Text] [Related]  

  • 19. Antigenic modulation as a mechanism for tumor escape from immune destruction: identification of modulation-positive and modulation-negative mouse lymphomas with xenoantisera to murine leukemia virus gp70.
    Stackpole CW; Cremona P; Leonard C; Stremmel P
    J Immunol; 1980 Oct; 125(4):1715-23. PubMed ID: 6251136
    [No Abstract]   [Full Text] [Related]  

  • 20. Isolation and partial characterization of a tumor-associated antigen of the P815 mastocytoma of DBA/2 mice.
    Al-Rammahy AK; Levy JG; Jackson AL
    J Immunol; 1980 Jan; 124(1):143-50. PubMed ID: 6765966
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.